Hubbard Radio Washington DC, LLC. All rights reserved. This website is not intended for users located within the European Economic Area.
ROCKVILLE, Md. (AP) _ MacroGenics Inc. (MGNX) on Tuesday reported a loss of $66.4 million in its first quarter.
On a per-share basis, the Rockville, Maryland-based company said it had a loss of $1.08.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 84 cents per share.
The biopharmaceutical company posted revenue of $11.1 million in the period.
What role does identity play at the Department of Defense as they look to the future?
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MGNX at https://www.zacks.com/ap/MGNX
© 2022 . All rights reserved. This website is not intended for users located within the European Economic Area.